Dr Alexander Sobinoff
People_

Dr Alexander Sobinoff

Conjoint Senior Lecturer
Children's Medical Research Institute
Faculty of Medicine and Health
Dr Alexander Sobinoff

Dr Sobinoff is a Senior Research Officer at the Children’s Medical Research Institute and a Senior lecturer at the University of Sydney’s Faculty of Medicine and Health. He is a molecular and cellular biologist with over 10 years’ research experience focusing on telomere biology and DNA damage/repair. Dr Sobinoff’s research has helped define the modern Alternative Lengthening of Telomeres (ALT) field, creating new internationally recognised methods for measuring telomere extension and identifying the first viable therapeutic target for ALT cancers.

Dr Sobinoff received his PhD in 2012 from the University of Newcastle, Australia. His dissertation on the effects of environmental chemicals on reproductive health received both national and international recognition, with articles detailing his research published in Time Magazine, Huffington Post Québec, and the daily mail UK. In 2013 Dr Sobinoff accepted a postdoctoral position examining telomere length maintenance with Assoc/Prof Pickett at the Children’s Medical Research Institute (CMRI), Sydney. In 2014 he received the prestigious Prof. Tony Basten Fellowship from the Sydney Medical School Foundation and was awarded a Cancer Institute NSW Early Career Fellowship in 2018. During his time at CMRI Dr Sobinoff has received several awards for his research on telomere length maintenance.

Dr Sobinoff has made several substantial discoveries regarding cancer cell telomere maintenance. These include defining the role of the BTR dissolvase and SLX1-SLX4 resolvase complexes in regulating break induced replication at ALT telomeres (Sobinoff et al., EMBO J 2017),identifying the FANCM-BTR complex as a suppressor of excessive telomere lengthening and that the disruption of this complex is selectively toxic to ALT cancer cells (Lu#, O’Rourke#, Sobinoff# et al., Nat Commun 2019), and the development of the first covalent binder of TRF2 that inhibits cancer cell growth (Sobinoff et al., Cell Chem Biol 2023).

My research program involves gene discovery using functional genomics to characterise mechanisms of cancer cell telomere length maintenance and repair. Telomeres are specialised DNA-protein structures which differentiate the ends of linear chromosomes from sites of DNA damage. Telomeres shorten during each round of cell division, eventually triggering cellular senescence and apoptosis when they become critically short. As part of oncogenesis, cancer cells must activate a telomere maintenance mechanism to lengthen their telomeres and achieve cellular immortality. Paradoxically, cancer cells have several telomere deficiencies brought about by replication stress, resulting in fragile and damaged telomeres. These deficiencies represent a unique vulnerability that can be exploited for the treatment of cancer.

I am currently investigating the different DNA damage repair pathways that converge at telomeres in cancer cells and the role of RNA/DNA binding proteins in regulating telomerase activity. I am also testing the efficacy of several telomere-based cancer therapies, including novel telomere targeting peptides and chemical inhibitors designed to induce mitotic catastrophe specifically in ALT cancer cells. Approximately 10% of all cancers rely on the ALT pathway of telomere maintenance to achieve replicative immortality. This percentage is significantly higher (~60%) in bone and soft tissue sarcomas, glioblastomas, pancreatic neuroendocrine tumours, and high-risk neuroblastomas. Collectively, these cancers account for approximately 2,500 new cases in Australia annually, with 150-180 of these cases occurring in children (20-25% of all children’s cancer).

Teaching Interests:
  • Cancer cell biology
  • Molecular biology
  • Cellular biology
  • DNA damage and repair

- The role of RNA binding proteins in the DNA replication stress response

- Investigating the role of a novel RNA binding protein in telomerase activity

- Cancer Institute NSW Early Career Fellow

- Australian Society for Medical Research

- The University of Sydney Cancer Research Network

- Kids Cancer Alliance

Cancer, Healthy Ageing, Lifespan
Project titleResearch student
Synthetic Lethality with FANCM inhibition in ALT-negative Cancer CellsJake SCHWENKE

Publications

Book Chapters

  • Sobinoff, A., Bernstein, I., McLaughlin, E. (2012). All Your Eggs in One Basket: Mechanisms of Xenobiotic Induced Female Reproductive Senescence. In Tetsuji Nagata (Eds.), Senescence, (pp. 559-584). Croatia: InTech.
  • Sobinoff, A., McLaughlin, E. (2010). Contraception Targets in Mammalian Ovarian Development. In Ursula-F. Habenicht and R. John Aitken (Eds.), Fertility Control, (pp. 45-66). Heidelberg Dordrecht London New York: Springer. [More Information]

Journals

  • Lu, R., Nelson, C., Rogers, S., Cesare, A., Sobinoff, A., Pickett, H. (2024). Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres. iScience, 27(1). [More Information]
  • Bruedigam, C., Porter, A., Song, A., Vroeg in de Wei, G., Stoll, T., Straube, J., Cooper, L., Cheng, G., Kahl, V., Sobinoff, A., Pickett, H., et al (2024). Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nature Cancer, 5(1), 47-65. [More Information]
  • Sobinoff, A., Pedone, P., Chambery, A., Cesare, A., Altucci, L., Pickett, H., Cosconati, S., Di Maro, S., Low, R., Benedetti, R., et al (2023). Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells. Cell Chemical Biology, 30(12), 1652-1665.e6. [More Information]

2024

  • Lu, R., Nelson, C., Rogers, S., Cesare, A., Sobinoff, A., Pickett, H. (2024). Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres. iScience, 27(1). [More Information]
  • Bruedigam, C., Porter, A., Song, A., Vroeg in de Wei, G., Stoll, T., Straube, J., Cooper, L., Cheng, G., Kahl, V., Sobinoff, A., Pickett, H., et al (2024). Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nature Cancer, 5(1), 47-65. [More Information]

2023

  • Sobinoff, A., Pedone, P., Chambery, A., Cesare, A., Altucci, L., Pickett, H., Cosconati, S., Di Maro, S., Low, R., Benedetti, R., et al (2023). Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells. Cell Chemical Biology, 30(12), 1652-1665.e6. [More Information]

2022

  • de Nonneville, A., Salas, S., Bertucci, F., Sobinoff, A., Adélaïde, J., Guille, A., Finetti, P., Noble, J., Churikov, D., Chaffanet, M., Pickett, H., Reddel, R., et al (2022). TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO Molecular Medicine, 14(10). [More Information]

2020

  • Sobinoff, A., Pickett, H. (2020). Mechanisms that drive telomere maintenance and recombination in human cancers. Current Opinion in Genetics & Development, 60, 25-30. [More Information]
  • Kahl, V., Allen, J., Nelson, C., Sobinoff, A., Lee, M., Kilo, T., Vasireddy, R., Pickett, H. (2020). Telomere Length Measurement by Molecular Combing. Frontiers in Cell and Developmental Biology, 8, 1-14. [More Information]

2019

  • Perera, O., Sobinoff, A., Teber, E., Harman, A., Maritz, M., Yang, S., Pickett, H., Cesare, A., Arthur, J., Mackenzie, K., Bryan, T. (2019). Telomerase promotes formation of a telomere protective complex in cancer cells. Science Advances, 5(10), 1-14. [More Information]
  • Lu, R., O'Rourke, J., Sobinoff, A., Allen, J., Nelson, C., Tomlinson, C., Lee, M., Reddel, R., Deans, A., Pickett, H. (2019). The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT). Nature Communications, 10(1), 1-14. [More Information]

2018

  • Sutherland, J., Sobinoff, A., Fraser, B., Redgrove, K., Siddall, N., Koopman, P., Hime, G., McLaughlin, E. (2018). RNA binding protein Musashi-2 regulates PIWIL1 and TBX1 in mouse spermatogenesis. Journal of Cellular Physiology, 233(4), 3262-3273. [More Information]

2017

  • Sobinoff, A., Pickett, H. (2017). Alternative Lengthening of Telomeres: DNA Repair Pathways Converge. Trends in Genetics, 33(12), 921-932. [More Information]
  • Sobinoff, A., Allen, J., Neumann, A., Yang, S., Walsh, M., Henson, J., Reddel, R., Pickett, H. (2017). BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres. EMBO Journal, 36(19), 2907-2919. [More Information]
  • Dagg, R., Pickett, H., Neumann, A., Napier, C., Henson, J., Teber, E., Arthur, J., Reynolds, C., Murray, J., Haber, M., Sobinoff, A., Lau, L., Reddel, R. (2017). Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres. Cell Reports, 19(12), 2544-2556. [More Information]

2015

  • Killedar, A., Stutz, M., Sobinoff, A., Tomlinson, C., Bryan, T., Beesley, J., Chenevix-Trench, G., Reddel, R., Pickett, H. (2015). A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genetics, 11(6), 1-23. [More Information]

2014

  • Sutherland, J., Fraser, B., Sobinoff, A., Pye, V., Davidson, T., Siddall, N., Koopman, P., Hime, G., McLaughlin, E. (2014). Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression. Biology Of Reproduction, 90(5), 92. [More Information]

2012

  • Sobinoff, A., Bernstein, I., McLaughlin, E. (2012). All Your Eggs in One Basket: Mechanisms of Xenobiotic Induced Female Reproductive Senescence. In Tetsuji Nagata (Eds.), Senescence, (pp. 559-584). Croatia: InTech.
  • Sobinoff, A., Nixon, B., Roman, S., McLaughlin, E. (2012). Staying alive: PI3K pathway promotes primordial follicle activation and survival in response to 3MC-induced ovotoxicity. Toxicological Sciences, 128(1), 258-271. [More Information]

2010

  • Sobinoff, A., McLaughlin, E. (2010). Contraception Targets in Mammalian Ovarian Development. In Ursula-F. Habenicht and R. John Aitken (Eds.), Fertility Control, (pp. 45-66). Heidelberg Dordrecht London New York: Springer. [More Information]

Selected Grants

2017

  • Targeting telomeric repeat-binding factor 2 TRF2 with small molecule inhibitors to promote a DNA damage response and prevent cancer cell growth, Sobinoff A, Pickett H, Cancer Institute NSW/Early Career Fellowship

2016

  • Developing a rapid and quantitative telomere length test to measure chemotherapeutic response to telomerase inhibition, Sobinoff A, Cancer Australia/Priority Driven Collaborative Cancer Research Scheme